These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16566013)

  • 1. Non-eIF2B-related cystic leukoencephalopathy of unknown origin.
    van der Knaap MS; Scheper GC
    Ann Neurol; 2006 Apr; 59(4):724. PubMed ID: 16566013
    [No Abstract]   [Full Text] [Related]  

  • 2. Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy.
    Mascalchi M; De Grandis D; Ginestroni A; Pratesi A; Della Nave R; Scheper GC; van der Knaap MS
    Neurology; 2006 Aug; 67(3):537-8. PubMed ID: 16894129
    [No Abstract]   [Full Text] [Related]  

  • 3. Dominant form of vanishing white matter-like leukoencephalopathy.
    Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
    Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis.
    Denier C; Orgibet A; Roffi F; Jouvent E; Buhl C; Niel F; Boespflug-Tanguy O; Said G; Ducreux D
    Neurology; 2007 May; 68(18):1538-9. PubMed ID: 17470759
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
    Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
    Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
    Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
    Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
    Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in functional study of EIF2B mutations in leukoencephalopathy with vanishing white matter].
    Leng XR; Wu Y; Jiang YW
    Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):125-8. PubMed ID: 21416999
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
    Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
    Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ovarioleukodystrophy.
    Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
    Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
    Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The large spectrum of eIF2B-related diseases.
    Fogli A; Boespflug-Tanguy O
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter.
    Matsui M; Mizutani K; Ohtake H; Miki Y; Ishizu K; Fukuyama H; Shimohata T; Onodera O; Nishizawa M; Takayama Y; Shibasaki H
    Eur Neurol; 2007; 57(1):57-8. PubMed ID: 17119336
    [No Abstract]   [Full Text] [Related]  

  • 14. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.
    Vanderver A; Hathout Y; Maletkovic J; Gordon ES; Mintz M; Timmons M; Hoffman EP; Horzinski L; Niel F; Fogli A; Boespflug-Tanguy O; Schiffmann R
    Neurology; 2008 Jun; 70(23):2226-32. PubMed ID: 18519871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing white matter disease in a child presenting with ataxia.
    Wilson CJ; Pronk JC; Van der Knaap MS
    J Paediatr Child Health; 2005; 41(1-2):65-7. PubMed ID: 15670229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of ovarioleukodystrophy without eIF2B mutations.
    Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
    J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing white matter disease: a review with focus on its genetics.
    Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS
    Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siblings with cystic leukoencephalopathy and megalencephaly.
    Yalçinkaya C; Comu S; Koçer N; Yüksel A; Gündüz E; Demirbilek V; Ocal A
    J Child Neurol; 2000 Oct; 15(10):690-3. PubMed ID: 11063084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.
    Mohammad-Qureshi SS; Jennings MD; Pavitt GD
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):658-64. PubMed ID: 18631136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.